Introduction:

Alopecia is a prevalent autoimmune disorder, which cause hair fall overall the body, and scalp. The most common reasons for hair fall are ageing, hormonal imbalance, cancer, depression and hypertension. Furthermore, increasing number of product launches, approvals, and robust pipeline of novel products is also expected to be the major driver for the alopecia treatment market.

North America dominates the alopecia treatment market and is expected to maintain its dominancy over the forecast period owing to increasing prevalence of alopecia, in the U.S. region.

The markets in Asia Pacific and Europe are expected to show significant growth rates in alopecia treatment market. Due to outburst of middle aged population in the region. Also, the population in Asia Pacific region is witnessing healthy growth in terms of GDP, which in turn is expected to propel growth at healthy digits. 

However, high cost and adverse effect of drugs coupled with failure of drugs related to emotional stress are major factor expected to hamper growth of the alopecia treatment market over the forecast period.

The alopecia treatment market has been segmented on the basis of disease type, drug type, by gender, by route of administration, by distribution channel, and region. The product type segment includes disease typeandrogenic alopecia, alopecia areata, ciatricial alopecia, traction alopecia, and alopecia totalis. On the basis of drug type the alopecia treatment market has been segmented into vasodilators, 5-alpha reductase inhibitors, corticosteroids, immunosuppressants, and others. On the basis of gender the alopecia treatment market has been segmented into male and female. On the basis of route of administration the alopecia treatment market has been segmented intooral, topical, and injectable. On the basis of distribution channel the alopecia treatment market has been segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

On the basis of region the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is expected to account major market share as compared to that of other regions.

Key players operating in the alopecia treatment market includes Histogen, Inc., Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., HCell Inc., GlaxoSmithKline Plc., Daiichi Sankyo, Inc., and Cipla Limited.

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
   • PORTER’s
   • Investment Outlook
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for Alopecia Treatment Strategies
     • Key Questions this Study will Answer

     • By Disease Type (Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, Alopecia Totalis)

       By Drug Type (Vasodilators, 5-Alpha Reductase Inhibitors, Corticosteroids, Immunosuppressants, and Others) By Gender (Male, and Female)

       By Route of Administration (Oral, Topical, and Injectable)

       By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

       By Region (North America, Latin America, Europe, Middle East, Asia Pacific, and Africa)

   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Overview
   • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
   • Y-o-Y Growth Analysis (%), 2020 – 2030
   • Regional Trends
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Regional Analysis
   • Regional Revenue Analysis
   • Regional By segment Analysis
   • Reasons for regional growth
   • Key Player of particular region
   • Countries Include in the report:

1. • • North America (U.S., Canada)
     • Europe (UK, France, Germany, Russia, Italy, Rest of Europe)
     • Asia Pacific (India, Japan, South Korea, China, Rest of Asia Pacific)
     • Latin America (Brazil, Mexico, Rest of Latin America)
     • Middle East & Africa (GCC, Israel, South Africa, Rest of Middle East)

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
   • Competitive Overview
   • Competitive Benchmarking
   • Market Share Analysis
   • Key Developments In The Alopecia Treatment Market
   • Key Developments: Mergers & Acquisitions
   • Key Developments: Collaboration
   • Key Developments: Contracts & Agreements
   • Key Developments: Expansion
   • Key Developments: Product Developments
2. Company Profiles

 

• Company Overview
• Product Portfolio
• Key Highlights
• Financial Performance
• Business Strategies
• SWOT Analysis

• • Histogen, Inc.

  • Aclaris Therapeutics, Inc.

  •  Concert Pharmaceuticals, Inc.

  • HCell Inc.

  • GlaxoSmithKline Plc.

  • Daiichi Sankyo, Inc.

  • Cipla Limited.

1. The Last Word
   • Future Impact
   • About Us
   • Contact